 |
 |
| BOARD OF DIRECTORS |
|
|
 William Doyle was originally part of the Vystar team as senior vice president of Sales and Marketing. His role expanded in November 2005 as he became company president and a member of the Board of Directors. Mr. Doyle assumed the role of chairman of the Board and CEO in April 2008 when Travis Honeycutt retired.
 J. Douglas Craft, Director, is the chief executive officer of the company he founded, Atlanta-based Medicraft Inc., one of the largest independent distributors for Medtronic since 1984. He has more than 28 years experience in the medical device arena and holds a Biomedical Engineering degree from Mississippi State University. Over the past ten years, Doug has been actively engaged in expanding the base of businesses to include Intraoperative Neuro-Monitoring, Orthopedics, Biologics, Interventional Pain therapies and Government contracting. He has also been involved in angel funding of many companies in the medical device arena.
 Mitsy Y. Mangum, Director, is vice president of Investments, Raymond James and Associates and is an accomplished investment professional with over 22 years of financial service and industry experience both from the retail side as well as the institutional side. Ms. Mangum’s career has included vice presidential positions with Smith Barney, Inc., Robinson-Humphrey Co. and Sterne Agee and Leach in addition to Raymond James. She has a Bachelor of Science in Business Administration/Management from College of Charleston. She has numerous professional designations, including NASD Series 7, 63, 65, 31, WMS; Georgia Department of Insurance: Life, Accident, Health and Sickness as well as Variable Annuity and Variable Life.
 D. Thomas Marsh, Director, is president of Centrotrade Minerals and Metals Inc. in Chesapeake, Va., a distributor of and technical advisory company for rubber, latex and chemicals. In his position, which he has held since 1999, Marsh directs day-to-day operations; provides technical, regulatory and standards organization oversight to sister groups in Europe and Asia; and administers material specifications and contracts.
An ASTM International member since 1990, Marsh currently serves as first vice chairman of Committee D11 on Rubber, chairman of Subcommittee D11.22 on Natural Rubber and as secretary of Subcommittee D11.23 on Synthetic Rubbers. He also served a term on the ASTM Committee on Technical Committee Operations (COTCO) from 2007 to 2009. He received a Distinguished Service Award from Committee D11 in 2007 and a Service Award from COTCO in 2009.
Marsh began his career as a technician for General Latex and Chemical Corp. in Ashland, Ohio, and then worked as a latex chemist for Abbott Laboratories from 1981 to 1987. He became laboratory and technical services manager for Ansell Inc. in Troy, Ala., and then president of the Ore and Chemical Corp. in Virginia Beach, Va., where he managed daily operations and implemented ASTM testing for natural rubber and latex. He was vice president of Microflex Corp., Reno, Nev., before joining Centrotrade.
In addition to ASTM International, Marsh is a member of the American Chemical Society, the American Management Association, the Ohio Rubber Group and the Rubber Trade Association of North America, where he is a member of the board of directors and a past president. He is also a U.S. voting delegate to Technical Committee 45 for Rubber and Rubber Goods of the International Organization for Standardization (ISO).
Marsh holds a general sciences degree from the Ohio State University and a bachelor's degree in business management from Liberty University, Lynchburg, Va., where he is currently working on his master’s degree in management and leadership.
Paul Yeoham, Director, is a founding partner of Progress Equity Partners, Ltd., a private equity investment firm that acquires majority control of well-managed, entrepreneurial, service-based businesses, and brings with him more than twenty years of financial and investment management experience to the board. Prior to forming Progress Equity, he was a senior partner at Transition Capital Partners, Ltd., a similar private equity firm. Mr. Yeoham joined Transition Capital Partners in 1993 as an associate, while the firm operated as Best Associates, and became a partner in 1996 when the firm changed its name to Best, Patterson, Crothers and Yeoham, Ltd. Mr. Yeoham received a Bachelor's Degree in Business Administration and Finance from the University of Texas at Arlington and a Master's Degree in Business from Southern Methodist University.
Mr. Yeoham currently serves on the boards of Terracare Associates and Oncology Molecular Imaging, LLC. He has previously served in a similar capacity for the boards of Texas Home Health Holdings, Inc., Tributary Systems, Inc., Digney York Associates, LLC, Network for Medical Communication and Research, LLC (NMCR), Conisus, LLC (Envision Communications) and more recently Westcon, Inc.
|
|
 Dean Waters is Vystar's Chief Financial Officer and the Founder and Managing Director of FiveFold Capital, a company focused on the capital needs of community banks. Mr. Waters has a diverse background and expertise in institutional investments, negotiations, domestic and international finance, due diligence, client relationship management and business development. He works on-site with each bank and draws upon his fifteen years of knowledge and experience in raising more than $5 billion in capital for middle-market to Fortune 1000 companies; and Community, Regional and Global Financial Institutions.
Prior to founding Five Fold Capital, Mr. Waters was Senior Vice President of Commerce Street Capital’s bank development group and was responsible for helping community bank management teams raise capital for initial and secondary offerings. Prior to Commerce Street, Mr. Waters was Managing Partner, Poseidon Capital Investments, LLC, an investment advisory firm. He was also Senior Vice President, Director and one of the founding members of the Capital Markets Group within GMAC Commercial Finance’s Equipment Finance Division. Before that, he was Managing Director of Equity Distributions of Bank of America Leasing & Capital Group.
Mr. Waters received a B.S. in Economics from East Carolina University in Greenville, N.C., and earned an M.B.A., with honors, from Wake Forest University’s Babcock Graduate School of Management in Winston-Salem, N.C. He also represented Wake Forest in the European Business Studies program at St. Peters College of Oxford University and served eight years on the Babcock Graduate School of Management’s Alumni Council. He currently serves as Secretary on the Board of Berkeley Hills Country Club in Duluth, Ga. as well as on the Board of Vystar Corporation, chairing the Audit Committee and serving on the Compensation Committee. Mr. Waters holds multiple securities licenses.
 Joseph C. Allegra, M.D., Director, is a native of Philadelphia but has been a resident of Atlanta for the past 20 years. Dr. Allegra received an A.B. degree (1970) from the College of Arts and Sciences at Temple University and his M.D. degree (1974) from Penn State University/Hershey Medical Center. Dr. Allegra did his Internal Medicine Training at the M S Hershey Medical Center and his Fellowship in Medical Oncology at the NIH/NCI. He is Board Certified in both Internal Medicine and Medical Oncology. He is married with three children.
In 1980, Dr. Allegra was recruited from the NIH by the University of Louisville and became its first Chief of Medical Oncology and Associate Director of the Brown Cancer Center. In 1982, he was promoted to Professor of Medicine and became the Chairman of the Department of Medicine and at age 34 was the youngest Chairman of a Department of Medicine in the history of medicine. His academic career continued until 1989 and he published over a hundred scientific articles, abstracts, books, and book chapters specializing in the treatment of breast cancer in women. He was also President of the Practice Group, University Medical Associates and during his tenure at the University expanded that group from 30 physicians to over 100 physicians. He was awarded the University of Louisville's Distinguished Teacher Award, Distinguished Administrator Award, and its Award for Superior Achievement in Affirmative Action.
Dr. Allegra transitioned from academic medicine to the health care business environment in 1989 becoming the President of T-2 Medical, a NYSE Ambulatory Care Company. Over a four year period, this company's revenue grew from 14M to 300M and its market cap from 200M to over 3B. Following T-2 Medical Dr. Allegra was employed by Phymatrix Inc., a publicly traded practice management company and worked directly for the Chairman and CEO making acquisitions of medical businesses throughout the USA. In 1997, Dr. Allegra and another physician, Dr. Stanley Winokur, founded the Network for Medical Communication and Research (NMCR) and over the next 10 years this company became the largest medical education company in cancer medicine in the USA. 60% of this company was sold in 2002 and the remainder in 2006. Since 2006, Dr. Allegra has founded two new companies, Oncology Molecular Imaging and Kid's Time Pediatrics, and serves on the Board of both companies as well as the Board of Cyber Investments. He also manages two investment LLCs, Diamond Investments and Diamond II Investments, which focus on alternative investments and is the owner of Lincoln Lee Investments which focuses on Private Equity in Health Care. He serves on the Board of Vystar as Chairman of its Executive Committee and Compensation Committee.
|
|
|
|